Pathological features of MS include perivascular inflammation and demyelination with oligodendrocyte loss; in addition, attempts at remyelination are of ten unsuccessful and may culminate in astrocytic scarring. One approach to investigating the biological principles underlying these processes is to use in vitro systems to analyse single-cell behaviour as well as cell-cell interactions. This paper reviews such data concerned with cell injury and repair which illuminate both demyelination and remyelination. In tissue culture oligodendrocytes are susceptible to injury via cell-mediated and humoral mechanisms. Substances including complement and tumour necrosis factor are capable of killing rat oligodendrocytes in vitro; surface complement activation also initiates a number of intracellular processes within oligodendrocytes as well as providing ligands for phagocytic interactions. The reasons for oligodendrocyte complement activation are discussed, but it appears that species differences exist when extrapolating these data to humans. Myelination and remyelination can also be studied both in vitro and in vivo using defined cell populations. Results from these studies may eventually help to explain some pathological features of MS, including astrocytosis and factors governing the limits of remyelination.
1 Carswell R. (1838) Atrophy. In: Pathological Anatomy. Illustration of Elementary Forms of Disease, Plate IV. Longman, Orme, Brown, Green and Longman: London.
2.
2 Cruveilher J. (1829–42) Anatomie Pathologique du Corps Humain, Vol. 2, Livraison 52, Plate 2. Ballière: Paris.
3.
3 Bornstein M, Murray MR. (1958) Serial observations on patterns of growth, myelin formation, maintenance and degeneration in cultures of newborn rat and kitten cerebellum. J Biophys Biochem Cytol4: 499.
4.
4 Bornstein M, Appel SH. (1961) The application of tissue culture to the study of experimental allergic encephalomyelitis. I. patterns of demyelination. J Neuropathol Exp Neurol20: 141.
5.
5 Bornstein M, Appel SH. (1965) Tissue culture studies of demyelination. Ann N Y Acad Sci122: 280–286.
6.
6 Lebar R et al. (1976) Studies on autoimmune encephalomyelitis in the guinea pig. II. An in vitro investigation on the nature, properties and specificity of the serum-demyelinating factor. J Immunol116: 1439–1446.
7.
7 Bornstein M, Iwamani H. (1971) Experimental allergic encephalomyelitis: demyelinating activity of serum and sensitized lymph node cells on cultured nerve tissues. J Neuropathol Exp Neurol30: 240–248.
8.
8 Bornstein M, Hummelgard A. (1976) Multiple sclerosis: serum induced demyelination in tissue culture. In: Shiraki H, Yonezawa T, Kuroiwa Y (eds). International Symposium on the Aetiology and Pathogenesis of the Demyelinating Diseases, Kyoto.Japanese Neurological Society: Tokyo, pp 341–350.
9.
9 Grundke-Iqbal I, Bornstein MB. (1979) Multiple sclerosis: immunochemical studies on the demyelinating serum factor. Brain Res160: 489–503.
10.
10 Grundke-Iqbal I, Bornstein MB. (1980) Multiple sclerosis: serum gamma globulin and demyelination in organ culture. Neurology30: 749–754.
11.
11 Hughes D, Field EJ. (1967) Myelotoxicity of serum and spinal fluid in multiple sclerosis: a critical assessment. Clin Exp Immunol2: 295–309.
12.
12 Bradbury K, Aparicio SR, Sumner DW, Bird CC. (1984) Role of complement in demyelination in vitro by multiple sclerosis serum and other neurological disease sera. J Neurol Sci65: 293–305.
13.
13 Silberberg DH, Manning MC, Schreiber AD. (1984) Tissue culture demyelination by normal human serum. Ann Neurol15: 575–580.
14.
14 Lumsden CE. (1971) The immunogenesis of the multiple sclerosis plaque. Brain Res28: 365–390.
15.
15 Selmaj KW, Bradbury K, Chapman J. (1988) Multiple sclerosis: effects of activated T-lymphocyte-derived products on organ cultures of nervous tissue. J Neuroimmunol18: 255–268.
16.
16 Selmaj KW, Raine CS. (1988) Tumour necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol23: 339–346.
17.
17 McCarthy KD, de Vellis J. (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol85: 890–902.
18.
18 Raff MC, Miller RH, Noble M. (1983) A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature303: 390–396.
19.
19 Hirayama M, Silberberg DH, Lisak RP, Pleasure D. (1983) Long term culture of oligodendrocytes isolated from rat corpus callosum by Percoll density gradient. J Neuropathol Exp Neurol42: 16–28.
20.
20 Szuchet S, Arnason BGW, Polak PE. (1978) A new method for oligodendrocyte isolation. Biophys J21: 51.
21.
21 Kim SU et al. (1984) Long term culture of human oligodendrocytes. Isolation, growth and identification. J Neurol Sci62: 295–301.
22.
22 Armstrong RC et al. (1992) Pre-oligodendrocytes from adult human CNS. J Neurosci12: 1538–1542.
23.
23 Scolding NJ et al. (1995) An adult human oligodendrocyte progenitor.Neuroreport (in press).
24.
24 Barres BA et al. (1992) Cell death and control of cell survival in the oligodendrocyte lineage. Cell70: 31–46.
25.
25 Wolswijk G, Riddle PN, Noble M. (1990) Coexistence of perinatal and adult forms of a glial progenitor cell during development of the rat optic nerve. Development109: 691–698.
26.
26 Kim SU. (1990) Neurobiology of human oligodendrocytes in culture. J Neurosci Res27: 712–728.
27.
27 Hirayama M, Lisak RP, Silberberg DH. (1986) Serum-mediated oligodendrocyte cytotoxicity in multiple sclerosis patients and controls. Neurology36: 276–278.
28.
28 Suzumura A, Lisak RP, Silberberg DH. (1986a) Serum cytotoxicity to oligodendrocytes in multiple sclerosis and controls: assessment by 51Cr release assay. J Neuroimmunol11: 137–147.
29.
29 Fewster ME, Ellis GW, Myers LW, Kurashige EY. (1975) Oligodendroglial toxicity by serum and lymphocytes from patients with multiple sclerosis. Neurology25: 735–739.
30.
30 Scolding NJ et al. (1989a) Normal rat serum cytotoxicity against syngeneic oligodendrocytes complement activation and attack in the absence of anti-myelin antibodies. J Neurol Sci89: 289–300.
31.
31 Scolding NJ et al. (1989b) Vesicular removal by oligodendrocytes of membrane attack complexes formed by complement. Nature339: 620–622.
32.
32 Wren DR, Noble M. (1989) Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in the absense of antibody. Proc Natl Acad Sci USA86: 9025–9029.
33.
33 Zajicek JP, Wing MG, Lachmann PJ, Compston DAS. (1992) Mechanisms of oligodendrocyte interaction with normal human serum-defining the role of complement. J Neurol Sci108: 65–72.
34.
34 Peltier AP, Cyna L, Dryll A. (1978) In vitro study of a reaction between the complement system and cellular DNA. Immunology35: 779.
35.
35 Pinckard PN et al. (1973) Antibody-independent activation of human C1 after interaction with heart subcellular membrane. J Immunol110: 1376.
36.
36 Loos M. (1982) Antibody-independent activation of C1 the first component of complement. Ann Immunol133C: 165.
37.
37 Cooper NR, Jensen FC, Welsh RM, Olstone MBA. (1976) Lysis of RNA tumour viruses by human serum: direct antibody independent triggering of classical complement pathway. J Exp Med144: 970.
38.
38 Martin H, McConnell I, Gorick B, Hughes-Jones NC. (1987) Antibody independent activation of the classical pathway of complement by Epstein-Barr virus. Clin Exp Immunol67: 531.
39.
39 Spear GT et al. (1990) Activation of complement on the surface of cells infected by human immunodefeciency virus. J Immunol144: 1490.
40.
40 Rogers J et al. (1992) Complement activation by beta-amyloid in Alzheimer's disease. Proc Natl Acad Sci USA89: 10016–10020.
41.
41 Lachmann PJ, Thompson RA. (1970) Reactive lysis: the complement mediated lysis of unsensitised cells. II. The characterisation of the activated reactor as C56 and the participation of C8 and C9. J Exp Med131: 643.
42.
42 Rollins SA, Sims PJ. (1990) The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J Immunol144: 3478.
43.
43 Meri S et al. (1990) Human protectin (CD59), an 18, 000–20, 000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology71: 1–9.
44.
44 Wing MG et al. (1992) Oligodendrocytes lack glycolipid anchored proteins which protect them against complement lysis. Restoration of resistance to lysis by incorporation of CD59. Immunology76: 140–145.
45.
45 Piddlesden SJ, Morgan BP. (1993) Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis. J Neuroimmunol48: 169–176.
46.
46 Ruijs TCG et al. (1990) Human oligodendrocytes are susceptible to cytolysis by major histocompatibility complex class I restricted lymphocytes. J Neuroimmunol27: 89–97.
47.
47 Zajicek JP, Wing M, Skepper J, Compston DAS. (1995) Human oligodendrocytes are not sensitive to complement-a study of CD59 expression in the human central nervous system.Lab Inv (in press).
48.
48 Prineas JW. (1985) The neuropathology of multiple sclerosis. In: Koetsier JC (ed). Handbook of Clinical Neurology: Demyelinating Diseases, Vol. 3 (47). Elsevier: Amsterdam, pp 213–257.
49.
49 Suzumura A, Mezitis SGE, Gonotas NK, Silberbeg DH. (1987) MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of 1a antigen expression by γ-interferon. J Neuroimmunol15: 263–278.
50.
50 Scolding NJ, Compston DAS. (1991) Oligodendrocyte-macrophage interactions in vitro triggered by specific antibodies. Immunology72: 127–132.
51.
51 Link et al. (1989) B cells and antibody in MS. Res Immunology140: 219–226.
52.
52 Olsson T, Baig S, Hojeberg B, Link H. (1990) Anti-myelin basic protein and anti-myelin antibody producing cells in multiple sclerosis. Ann Neurol37: 132–136.
53.
53 Xiao B-G, Linington C, Link H. (1991). Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J Neuroimmunol31: 91–96.
54.
54 Zajicek JP, Wing M, Scolding NJ, Compston DAS. (1992b) Interactions between oligodendrocytes and microglia: a major role for complement and tumour necrosis factor in oligodendrocyte adherence and killing. Brain115: 1611–1631.
55.
55 Savill J, Dransfield I, Hogg N, Haslett C. (1990) Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature343: 170–173.
56.
56 Akiyama H, Kawamata T, Dedhar S, McGeer PL. (1991) Immunohistochemical localisation of vitronectin, its receptor and beta-3 integrin in Alzheimer brain tissue. J Neuroimmunol32: 19–28.
57.
57 Wood A, Wing MG, Benham CD, Compston DAS. (1993) Specific induction of intracellular calcium oscillations by complement membrane attack on oligodendroglia. J Neurosci13: 3319–3332.
58.
58 Vanguri P, Shin ML. (1986) Activation of complement by myelin: identification of C1-binding proteins by human myelin from central nervous tissue. J Neurochem46: 1535.
59.
59 Hansch GM, Betz M, Shin ML. (1984) Cytolysis of nucleated cells by complement: inhibition of membrane transmethylation enhances cell death by C5b-9. J Immunol132: 1440.
60.
60 Roberts PA, Morgan BP, Campbell AK. (1985) 2-Chloroadenosine inhibits complement-induced reactive oxygen metabolite production and recovery of human polymorphonuclear leucocyte attacked by complement. Biochem Biophys Res Commun126: 692.
61.
61 Imagawa DK et al. (1983) Consequences of cell membrane attack by complement: release of arachidonate and formation of inflammatory derivatives. Proc Natl Acad Sci USA80: 6647.
62.
62 Hansch GM, Gemsa D, Resch K. (1985) Induction of prostanoid synthesis in human platelets by the late complement components C5b-9 and channel forming antibiotic nystatin: inhibition of the reacylation of liberated arachidonic acid. J Immunol135: 1320.
63.
63 Shirazi Y, Rus HG, Macklin WB, Shin ML. (1993) Enhanced degradation of messenger RNA encoding myelin proteins by terminal complement complexes in oligodendrocytes. J Immunol150: 4581–4590.
64.
64 Selmaj K et al. (1991) Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol147: 1522–1529.
65.
65 Merrill JE. (1991) Effects of interleukin-1 and tumour necrosis factor-α on astrocytes, microglia, oligodendrocytes and glial precursors in vitro. Dev Neurosci13: 130–137.
66.
66 Kim YS, Kim SU. (1991) Oligodendroglial cell death induced by oxygen radicals and its protection by catalase. J Neurosci Res29: 100–106.
67.
67 Wong GHW et al. (1984) Inducible expression of H-2 and Ia antigens on brain cells. Nature310: 688–691.
68.
68 Suzumura A, Lavi E, Weiss SR, Silberberg DH. (1986b) Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes. Science232: 991–993.
69.
69 Bergsteinsdottir K, Brennan A, Jessen KR, Mirsky R. (1992) In the presence of dexamethasone, γ-interferon induces rat oligodendrocytes to express major histocompatibility complex class II molecules. Proc Natl Acad Sci USA89: 9054–9058.
70.
70 Wong GHW et al. (1985) Interferon-γ induces the expression of H-2 and Ia antigens on brain cells. J Neuroimmunol7: 255–278.
71.
71 Massa PT, Dorries R, ter Meulen V. (1986) Viral particles induce 1a expression on astrocytes. Nature320: 543–546.
72.
72 Fierz W, et al. (1985) Astrocytes as antigen-presenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation. J Immunol134: 3785–3793.
73.
73 Massa PT, ter Meulen V, Fontana A. (1987) Hyperinducibility of 1a antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA84: 4219–4223.
74.
74 Lisak RP, et al. (1983) Cultured human and rat oligodendrocytes and rat Schwann cells do not have immune response gene associated antigen (Ia) on their surface. Brain Res289: 285–292.
75.
75 Mauerhoff T, Pujol-Borrell R, Mirakian R, Bottazzo GF. (1988) Differential expression and regulation of major histocompatibility complex (MHC) products in neural and glial cells of the human foetal brain. J Neuroimmunol18: 271–289.
76.
76 Kim SU, Moretto G, Shin DH. (1985) Expression of Ia antigens on the surface of human oligodendrocytes and astrocytes in culture. J Neuroimmunol10: 141–149.
77.
77 Yong VW et al. (1991) Expression and modulation of HLA-DR on cultured human adult astrocytes. J Neuropathol Exp Neurol50: 16–28.
78.
78 Grenier Y et al. (1989) Immunohistochemical studies of adult human glial cells. J Neuroimmunol21: 103–115.
79.
79 Pulver M, Carrel S, Mach JP, de Tribolet N. (1987) Cultured human foetal astrocytes can be induced by interferon-γ to express HLA-DR. J Neuroimmunol14: 123–133.
80.
80 Scolding NJ, Jones J, Compston DAS, Morgan BP. (1990) Oligodendrocyte susceptibility to injury by T-cell perforin. Immunology70: 6–10.
81.
81 Kawai K, Zweiman B. (1988) Cytotoxic effect of myelin basic protein-reactive T cells on cultured oligodendrocytes. J Neuroimmunol19: 159–165.
82.
82 Jewtoukoff V, Lebar R, Bach M-A. (1989) Oligodendrocyte-specific autoreactive T cells using an a/b T-cell receptor kill their target without self restriction. Proc Natl Acad Sci USA86: 2824–2828.
83.
83 Harding CV, Unanue ER. (1990) Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature346: 574–576.
84.
84 Fontana A, Fierz W, Wekerle H. (1984) Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature307: 273–276.
85.
85 McCarron RM et al. (1985) Presentation of myelin basic proteins by murine cerebral vascular endothelial cells. J Immunol134: 3100.
86.
86 McCarron RM et al. (1986) Interaction between myelin basic protein-sensitised T lymphocytes and murine cerbral vascular endothelial cells. J Immunol137: 3428–3435.
87.
87 Wilcox CE et al. (1989) Differential expression of guinea pig class II major histocompatibility complex antigens on vascular endothelial cells in vitro and in experimental allergic encephalitis. Cell Immunol120: 82–91.
88.
88 Male D, Pryce G. (1989) Induction of Ia molecules on brain endothelium is related to susceptibility to experimental allergic encephalomyelitis. J Neuroimmunol21: 87–90.
89.
89 Matthieu J-M et al. (1978) Myelination in rat brain aggregating cell cultures. Neuroscience3: 565–572.
90.
90 Zajicek JP, Compston DAS. (1994) Myelination in vitro of rodent dorsal root ganglia by glial progenitor cells. Brain117: 1333–1350.
91.
91 Wood PM, Bunge RP. (1984) Evidence that axons are mitogenic for oligodendrocytes isolated from adult animals. Nature320: 756–758.
92.
92 Bray GM, Rasminsky M, Aguayo AJ. (1981) Interactions between axons and their sheath cells. Annu Rev Neurosci4: 127–162.
93.
93 Carey DJ, Bunge RP. (1981) Factors influencing the release of proteins in cultured Schwann cells. J Cell Biol91: 666–672.
94.
94 Bunge MB, Williams AK, Wood PM. (1982) Neuron-Schwann cell interaction in basal lamina formation. Develop Biol92: 449–460.
95.
95 Jessen KR, Mirsky R, Morgan L. (1991) Role of cyclic AMP and proliferation controls in Schwann cell differentiation. Ann NY Acad Sci633: 78–89.
96.
96 Hardy R, Reynolds R. (1991) Proliferation and differentiation potential of rat forebrain oligodendroglial progenitors both in vitro and in vivo. Development111: 1061–1080.
97.
97 Warrington AE, Barbarese E, Pfeiffer SE. (1993) Differential myelinogenic capacity of specific developmental stages of the oligodendrocyte lineage upon transplantation into hypomyelinating hosts. J Neurosci Res34: 1–13.
98.
98 Ranscht G et al. (1982) Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside. Proc Natl Acad Sci USA75: 2521.
99.
99 Bansal R et al. (1990) Characterization of monoclonal antibodies O1, O4 and R-mAb used in the analysis of oligodendrocyte development. Ann N Y Acad Sci USA605: 409–411.
100.
100 Lassmann H, Suchanek G, Ozawa K. (1994) Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis. Ann Neurol36: S42–45.
101.
101 Wood PM, Williams AK. (1984). Oligodendrocyte proliferation and CNS myelination in cultures containing dissociated embryonic neuroglia and dorsal root ganglion neurons. Dev Brain Res12: 225–241.
102.
102 Wood PM, Bunge RP. (1986) Myelination of cultured dorsal root ganglion neurons by oligodendrocytes obtained from adult rats. J Neurol Sci74: 153–169.
103.
103 Chen SJ, De Vries GH. (1989) The mitogenic effect of the axolemma-enriched fraction on cultured oligodendrocytes. J Neurochem52: 325.
104.
104 Barres BA, Raff MC. (1993) Proliferation of oligodendrocyte precursor cells depends on electrical activity in axons. Nature361: 258–260.
105.
105 Dutley F, Schwab ME. (1991) Neurons and astrocytes influence the development of purified O-2A progenitor cells. Glia4: 559–571.
106.
106 McKinnon RD, Dubois-Dalcq M. (1990) Fibroblast growth factor blocks myelin basic protein gene expression in differentiating O-2A glial progenitor cells. Ann NY Acad Sci605: 358–359.
107.
107 Elde R et al. (1991) Prominent expression of acidic fibroblast growth factor in motor and sensory neurons. Neuron7: 349–364.
108.
108 Wilcox BT, Unnerstall JR. (1991) Expression of acidic fibroblast growth factor mRNA in the developing and adult rat brain. Neuron6: 397–409.
109.
109 Lillien LE, Sendtner M, Raff MC. (1990) Extracellular matrix-associated molecules collaborate with ciliary neurotrophic factor to induce type-2 astrocyte development. J Cell Biol111: 635–644.
110.
110 Levison SW, McCarthy KD. (1990) Partial purification of a serum protein that induces the differentiation of type-2 astroglia. In: Levi G (ed) Differentiation and Functions of Glial Cells: Procedings of a Satellite Meeting of the International Society for Neurochemistry held in Rome, Italy, April 19–21 1989.Alan R Liss: New York, pp 103–105.
111.
111 Barres BA, Schmid R, Sendnter M, Raff MC. (1993) Multiple extracellular signals are required for long-term oligodendrocyte survival. Development118: 283–295.
112.
112 Yamamori T et al. (1989) The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. Science246: 1412–1416.
113.
113 Zarling JM et al. (1986) Oncostatin M: a growth regulator produced by differential histiocytic lymphoma cells. Proc Natl Acad Sci USA83: 9739–9743.
114.
114 Patterson PH. (1992) The emerging neuropoietic cytokine family: first CDF/LIF, CNTF and IL-6; next ONC, MGF, GCSF? Curr Opin Neurobiol2: 94–97.
115.
115 Hildebrand C. (1971) Ultrastructural and light-microscopic studies of the nodal region in large myelinated fibres of the adult feline spinal cord white matter.Acta Physiol Scand (suppl.) 364: 43–78.
116.
116 Black JA et al. (1989) Sodium channels in astrocytes of rat optic nerve in situ: immuno-electron microscopic studies. Glia2: 353–369.
117.
117 Gray PTA, Ritchie JM. (1985) Ion channels in Schwann and glial cells. Trends Neurosci8: 411–415.
118.
118 ffrench-Constant C, Raff MC. (1986) The oligodendro-cyte-type-2 astrocyte cell lineage is specialised for myelination. Nature323: 335–338.
119.
119 Waxman SG, Ritchie JM. (1993) Molecular dissection of the myelinated axon. Ann Neurol33: 121–136.
120.
120 Levison SW, Goldman JE. (1993) Both oligodendrocytes and astrocytes develop from preogenitors in the sub-ventricular zone of postnatal rat forebrain. Neuron10: 201–212.
121.
121 Blakemore WF. (1973) Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding cuprizone. J Neurol Sci20: 73–83.
122.
122 Blakemore WF. (1982) Ethidium bromide induced demyelination in the spinal cord of the cat. Neuropathol Appl Neurobiol8: 365–375.
123.
123 Ludwin SK. (1978) Central nervous system demyelination and remyelination in the mouse, an ultrastructural study of cuprizone toxicity. Lab Invest39: 597–612.
124.
124 Stidworthy Johnson E, Ludwin SK. (1981) The demonstration of recurrent demyelination and remyelination of axons in the central nervous system. Acta Neuropathol53: 93–98.
125.
125 Groves AK et al. (1993) Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells. Nature326: 453–455.
126.
126 Blakemore WF, Franklin RJM. (1991a) Transplantation of glial cells into the CNS. Trends Neurosci14: 323–327.
127.
127 Ludwin SK. (1979) An autoradiographic study of cellular proliferation in remyelination of the central nervous system. Am J Pathol95: 683–696.
128.
128 Mori S, Leblond CP. (1970) Electron microscopic identification of three classes of oligodendrocytes and a preliminary study of their proliferative activity in the corpus callosum of young rats.J Comp Neurol139: 1–30.
129.
129 Ludwin SK. (1984) Proliferation of mature oligodendrocytes after trauma to the central nervous system. Nature308: 274–275.
130.
130 Ludwin SK. (1985) Reaction of oligodendrocytes and astrocytes to trauma and implantation a combined autoradiographic and immunohistochemical study. Lab Invest52: 20–30.
131.
131 Crang AJ et al. (1992) The differentiation of glial cell progenitor populations following transplantation into non-repairing central nervous system glial lesions in adult animals. J Neuroimmunol40: 243–254.
132.
132 Franklin RJM. (1993) Reconstructing myelin-deficient environments in the CNS by glial cell transplantation. Semin Neurosci5 (in press).
133.
133 Barnett SC, Franklin RJM, Blakemore WF. (1993) In vitro and in vivo analysis of a rat bipotential O-2 A progenitor cell line containing the temperature-sensitive mutant gene of the SV40 large T antigen. Eur J Neurosci5: 1247–1260.
134.
134 Trotter J et al. (1993) Lines of glial precursor cells immortalised with a temperature-sensitive oncogene give rise to astrocytes and oligodendrocytes following transplantation into demyelinated lesions in the central nervous system. Glia9: 25–40.
135.
135 Lachapelle F et al. (1984) Transplantation of CNS fragments into brain shiverer mutant mice: extensive myelination by implanted oligodendrocytes. Dev Neurosci6: 325–334.
136.
136 Carroll WM, Jennings AR. (1994) Early recruitment of oligodendrocyte precursors in CNS demyelination.Brain117: 563–578.
137.
137 Ludwin SK, Szuchet S. (1993) Myelination by mature ovine oligodendrocytes in vivo and in vitro: evidence that different steps in the myelination process are independently controlled. Glia8: 219–231.
